Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers
COVID-19 vaccination has proven to be effective at preventing symptomatic disease but there are scarce data to fully understand whether vaccinated individuals can still behave as SARS-CoV-2 transmission vectors. Based on viral genome sequencing and detailed epidemiological interviews, we report a nosocomial transmission event involving two vaccinated health care-workers (HCWs) and four patients, one of them with fatal outcome. Strict transmission control measures, as during the prevaccination period, must be kept between HCWs and HCWs-patients in nosocomial settings. IMPORTANCE COVID-19 vaccination has proven to be effective at preventing symptomatic disease. Although some transmission events involving vaccinated cases have also been reported, scarce information is still available to fully understand whether vaccinated individuals may still behave as vectors in SARS-CoV-2 transmission events. Here, we report a SARS-CoV-2 nosocomial transmission event, supported on whole genome sequencing, in early March 2021 involving two vaccinated HCWs and four patients in our institution. Strict transmission control measures between HCWs and HCWs - patients in nosocomial settings must not be relaxed, and should be kept as strictly as during the prevaccination period.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Microbiology spectrum - 10(2022), 1 vom: 23. Feb., Seite e0153221 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pérez-Lago, Laura [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 04.03.2022 Date Revised 20.10.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1128/spectrum.01532-21 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM335207014 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM335207014 | ||
003 | DE-627 | ||
005 | 20231225225328.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1128/spectrum.01532-21 |2 doi | |
028 | 5 | 2 | |a pubmed24n1117.xml |
035 | |a (DE-627)NLM335207014 | ||
035 | |a (NLM)34985301 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pérez-Lago, Laura |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.03.2022 | ||
500 | |a Date Revised 20.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a COVID-19 vaccination has proven to be effective at preventing symptomatic disease but there are scarce data to fully understand whether vaccinated individuals can still behave as SARS-CoV-2 transmission vectors. Based on viral genome sequencing and detailed epidemiological interviews, we report a nosocomial transmission event involving two vaccinated health care-workers (HCWs) and four patients, one of them with fatal outcome. Strict transmission control measures, as during the prevaccination period, must be kept between HCWs and HCWs-patients in nosocomial settings. IMPORTANCE COVID-19 vaccination has proven to be effective at preventing symptomatic disease. Although some transmission events involving vaccinated cases have also been reported, scarce information is still available to fully understand whether vaccinated individuals may still behave as vectors in SARS-CoV-2 transmission events. Here, we report a SARS-CoV-2 nosocomial transmission event, supported on whole genome sequencing, in early March 2021 involving two vaccinated HCWs and four patients in our institution. Strict transmission control measures between HCWs and HCWs - patients in nosocomial settings must not be relaxed, and should be kept as strictly as during the prevaccination period | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a genomics | |
650 | 4 | |a nosocomial | |
650 | 4 | |a transmission | |
650 | 4 | |a vaccination | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
700 | 1 | |a Machado, Marina |e verfasserin |4 aut | |
700 | 1 | |a Gómez-Ruiz, María de Mar |e verfasserin |4 aut | |
700 | 1 | |a Sola-Campoy, Pedro J |e verfasserin |4 aut | |
700 | 1 | |a Buenestado-Serrano, Sergio |e verfasserin |4 aut | |
700 | 1 | |a de la Cueva-García, Victor Manuel |e verfasserin |4 aut | |
700 | 1 | |a Herranz, Marta |e verfasserin |4 aut | |
700 | 1 | |a Andrés Zayas, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-Arcilla, Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Flores-García, Rubén Francisco |e verfasserin |4 aut | |
700 | 1 | |a López-Fresneña, Nieves |e verfasserin |4 aut | |
700 | 1 | |a García de San José, Sonia |e verfasserin |4 aut | |
700 | 1 | |a Catalán, Pilar |e verfasserin |4 aut | |
700 | 1 | |a Muñoz, Patricia |e verfasserin |4 aut | |
700 | 1 | |a García de Viedma, Darío |e verfasserin |4 aut | |
700 | 0 | |a Gregorio Marañón Microbiology-ID COVID 19 Study Group |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Microbiology spectrum |d 2013 |g 10(2022), 1 vom: 23. Feb., Seite e0153221 |w (DE-627)NLM241847044 |x 2165-0497 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2022 |g number:1 |g day:23 |g month:02 |g pages:e0153221 |
856 | 4 | 0 | |u http://dx.doi.org/10.1128/spectrum.01532-21 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2022 |e 1 |b 23 |c 02 |h e0153221 |